Veracyte’s fair value estimate has been raised slightly and now sits at $41.22 per share, up from the previous $39.75. This modest increase comes as analysts weigh new research and updated company ...

Former UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling ...

A double-pronged attack on advanced prostate cancer could help treat as many as two in five patients with late-stage disease, ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

Scientists have found a new method that could treat patients with advanced prostate cancer. Experts at The Institute of Cancer Research, London, found that a two-pronged method could help treat as ...

Double-pronged attack on advanced prostate cancer shows promise - Patients could one day be treated with the new combination ...

Daryl Wilber had his gallbladder removed due to painful gallstones. The regular post-op appointments showed high PSA levels, which led to a prostate biopsy.